AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers.

Saved in:
Bibliographic Details
Title: AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers.
Authors: Belmontes B; Amgen Research, Thousand Oaks, California., Slemmons KK; Amgen Research, Thousand Oaks, California., Su C; Amgen Research, South San Francisco, California., Liu S; Amgen Research, Thousand Oaks, California., Policheni AN; Amgen Research, Thousand Oaks, California., Moriguchi J; Amgen Research, Thousand Oaks, California., Tan H; Amgen Research, Thousand Oaks, California., Xie F; Amgen Research, South San Francisco, California., Aiello DA; Amgen Research, Thousand Oaks, California., Yang Y; Amgen Research, Thousand Oaks, California., Lazaro R; Amgen Research, Thousand Oaks, California., Aeffner F; Amgen Research, South San Francisco, California., Rees MG; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Ronan MM; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Roth JA; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Vestergaard M; Amgen Research, Copenhagen, Denmark., Cowland S; Amgen Research, Copenhagen, Denmark., Andersson J; Amgen Research, Copenhagen, Denmark., Sarvary I; Amgen Research, Copenhagen, Denmark., Chen Q; Amgen Research, Thousand Oaks, California., Sharma P; Amgen Research, Thousand Oaks, California., Lopez P; Amgen Research, Thousand Oaks, California., Tamayo N; Amgen Research, Thousand Oaks, California., Pettus LH; Amgen Research, Thousand Oaks, California., Ghimire-Rijal S; Amgen Research, Thousand Oaks, California., Mukund S; Amgen Research, South San Francisco, California., Allen JR; Amgen Research, Thousand Oaks, California., DeVoss J; Amgen Research, South San Francisco, California., Coxon A; Amgen Research, Thousand Oaks, California., Rodon J; MD Anderson, Houston, Texas., Ghiringhelli F; Centre Georges François Leclerc, Dijon, France., Penel N; Centre Oscar Lambret, Lille, France., Prenen H; Universitair Ziekenhuis Antwerpen, Edegem, Belgium., Glad S; Amgen Research, Copenhagen, Denmark., Chuang CH; Amgen Research, South San Francisco, California., Keyvanjah K; Amgen Research, Thousand Oaks, California., Townsley DM; Amgen Research, Thousand Oaks, California., Butler JR; Amgen Research, Thousand Oaks, California., Bourbeau MP; Amgen Research, Thousand Oaks, California., Caenepeel S; Amgen Research, Thousand Oaks, California., Hughes PE; Amgen Research, Thousand Oaks, California.
Source: Cancer discovery [Cancer Discov] 2025 Jan 13; Vol. 15 (1), pp. 139-161.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39282709
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Belmontes+B%22">Belmontes B</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Slemmons+KK%22">Slemmons KK</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Su+C%22">Su C</searchLink>; Amgen Research, South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Liu+S%22">Liu S</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Policheni+AN%22">Policheni AN</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Moriguchi+J%22">Moriguchi J</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Tan+H%22">Tan H</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Xie+F%22">Xie F</searchLink>; Amgen Research, South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Aiello+DA%22">Aiello DA</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Lazaro+R%22">Lazaro R</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Aeffner+F%22">Aeffner F</searchLink>; Amgen Research, South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Rees+MG%22">Rees MG</searchLink>; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ronan+MM%22">Ronan MM</searchLink>; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Roth+JA%22">Roth JA</searchLink>; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Vestergaard+M%22">Vestergaard M</searchLink>; Amgen Research, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Cowland+S%22">Cowland S</searchLink>; Amgen Research, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Andersson+J%22">Andersson J</searchLink>; Amgen Research, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Sarvary+I%22">Sarvary I</searchLink>; Amgen Research, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Chen+Q%22">Chen Q</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Sharma+P%22">Sharma P</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Lopez+P%22">Lopez P</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Tamayo+N%22">Tamayo N</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Pettus+LH%22">Pettus LH</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Ghimire-Rijal+S%22">Ghimire-Rijal S</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Mukund+S%22">Mukund S</searchLink>; Amgen Research, South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Allen+JR%22">Allen JR</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22DeVoss+J%22">DeVoss J</searchLink>; Amgen Research, South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Coxon+A%22">Coxon A</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Rodon+J%22">Rodon J</searchLink>; MD Anderson, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Ghiringhelli+F%22">Ghiringhelli F</searchLink>; Centre Georges François Leclerc, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Penel+N%22">Penel N</searchLink>; Centre Oscar Lambret, Lille, France.<br /><searchLink fieldCode="AU" term="%22Prenen+H%22">Prenen H</searchLink>; Universitair Ziekenhuis Antwerpen, Edegem, Belgium.<br /><searchLink fieldCode="AU" term="%22Glad+S%22">Glad S</searchLink>; Amgen Research, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Chuang+CH%22">Chuang CH</searchLink>; Amgen Research, South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Keyvanjah+K%22">Keyvanjah K</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Townsley+DM%22">Townsley DM</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Butler+JR%22">Butler JR</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Bourbeau+MP%22">Bourbeau MP</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Caenepeel+S%22">Caenepeel S</searchLink>; Amgen Research, Thousand Oaks, California.<br /><searchLink fieldCode="AU" term="%22Hughes+PE%22">Hughes PE</searchLink>; Amgen Research, Thousand Oaks, California.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101561693%22">Cancer discovery</searchLink> [Cancer Discov] 2025 Jan 13; Vol. 15 (1), pp. 139-161.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101561693 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2159-8290 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221598274%22">21598274 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Discov <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39282709
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2159-8290.CD-24-0887
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 139
    Titles:
      – TitleFull: AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Belmontes B
      – PersonEntity:
          Name:
            NameFull: Slemmons KK
      – PersonEntity:
          Name:
            NameFull: Su C
      – PersonEntity:
          Name:
            NameFull: Liu S
      – PersonEntity:
          Name:
            NameFull: Policheni AN
      – PersonEntity:
          Name:
            NameFull: Moriguchi J
      – PersonEntity:
          Name:
            NameFull: Tan H
      – PersonEntity:
          Name:
            NameFull: Xie F
      – PersonEntity:
          Name:
            NameFull: Aiello DA
      – PersonEntity:
          Name:
            NameFull: Yang Y
      – PersonEntity:
          Name:
            NameFull: Lazaro R
      – PersonEntity:
          Name:
            NameFull: Aeffner F
      – PersonEntity:
          Name:
            NameFull: Rees MG
      – PersonEntity:
          Name:
            NameFull: Ronan MM
      – PersonEntity:
          Name:
            NameFull: Roth JA
      – PersonEntity:
          Name:
            NameFull: Vestergaard M
      – PersonEntity:
          Name:
            NameFull: Cowland S
      – PersonEntity:
          Name:
            NameFull: Andersson J
      – PersonEntity:
          Name:
            NameFull: Sarvary I
      – PersonEntity:
          Name:
            NameFull: Chen Q
      – PersonEntity:
          Name:
            NameFull: Sharma P
      – PersonEntity:
          Name:
            NameFull: Lopez P
      – PersonEntity:
          Name:
            NameFull: Tamayo N
      – PersonEntity:
          Name:
            NameFull: Pettus LH
      – PersonEntity:
          Name:
            NameFull: Ghimire-Rijal S
      – PersonEntity:
          Name:
            NameFull: Mukund S
      – PersonEntity:
          Name:
            NameFull: Allen JR
      – PersonEntity:
          Name:
            NameFull: DeVoss J
      – PersonEntity:
          Name:
            NameFull: Coxon A
      – PersonEntity:
          Name:
            NameFull: Rodon J
      – PersonEntity:
          Name:
            NameFull: Ghiringhelli F
      – PersonEntity:
          Name:
            NameFull: Penel N
      – PersonEntity:
          Name:
            NameFull: Prenen H
      – PersonEntity:
          Name:
            NameFull: Glad S
      – PersonEntity:
          Name:
            NameFull: Chuang CH
      – PersonEntity:
          Name:
            NameFull: Keyvanjah K
      – PersonEntity:
          Name:
            NameFull: Townsley DM
      – PersonEntity:
          Name:
            NameFull: Butler JR
      – PersonEntity:
          Name:
            NameFull: Bourbeau MP
      – PersonEntity:
          Name:
            NameFull: Caenepeel S
      – PersonEntity:
          Name:
            NameFull: Hughes PE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 01
              Text: 2025 Jan 13
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2159-8290
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer discovery
              Type: main
ResultId 1